home

LATEST ONCOPRESCRIBE UPDATES

• Adjuvant VERZENIO® with Endocrine Therapy in High Risk Early Stage Breast Cancer

• PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma

• First Line KEYTRUDA® Superior to Chemotherapy in Metastatic MSI-H/dMMR Colorectal Cancer

• Genomics Identify Patients with Smoldering Myeloma at Risk of Developing Multiple Myeloma

SHOW MORE

FDA
Approvals

Meeting
Updates

Hem/Onc
Updates

Symptom
Management

NEW REGIMENS ADDED

Research Regimens

• OPDIVO® and YERVOY® - for Malignant Melanoma

• OPDIVO® and YERVOY® - for Non Small Cell Lung Cancer

• OPDIVO® and YERVOY® with Limited Course Chemotherapy - for Non Small Cell Lung Cancer (Adenocarcinoma)

• Single Agent PEMAZYRE® - for Cholangiocarcinoma

• PARAPLATIN® and VEPESID® with IMFINZI® - for Small Cell Lung Cancer

Curbside Consultation

Renal Cell Carcinoma Special Issue

Immuno-Oncology

Precision Oncology

• COVID-19 Associated Coagulopathy: Diagnosis and Management
  

• Dual Inhibition Improves Outcomes for Patients with BRAF-Mutated Colorectal Tumors
  

SHOW MORE